Table 2 Unadjusted lifetime prevalence and cumulative incidence of the eight disease outcomes investigated
Lifetime Prevalence Cases/Persons at risk (weighted %) | Incidence Cases/Persons at risk (weighted %) | ||||
|---|---|---|---|---|---|
Wave 1 | Wave 3 | Wave 5 | 4-Year | 8-Year | |
Hypertension | 2390/5680 (43.82%) | 2524/4814 (53.56%) | 2255/3950 (61.11%) | 545/2835 (19.70%) | 716/2411 (32.12%) |
High Cholesterol | 2733/5680 (48.67%) | 2977/4814 (62.17%) | 2688/3950 (69.13%) | 650/2487 (26.15%) | 808/2068 (39.35%) |
Diabetes | 423/5680 (8.34%) | 471/4814 (10.16%) | 455/3950 (12.74%) | 130/4473 (2.94%) | 195/3690 (5.45%) |
Respiratory Diseases | 757/5680 (13.42%) | 803/4814 (16.99%) | 743/3950 (20.25%) | 186/4197 (4.59%) | 250/3206 (8.16%) |
Arthritis | 1578/5680 (28%) | 1878/4814 (39.9%) | 1750/3950 (47.63%) | 557/3493 (16.25%) | 711/2911 (26.16%) |
Osteoporosis | 370/5680 (10.27%) | 1002/4814 (20.96%) | 1002/3950 (26.36%) | 434/4246 (10.22%) | 547/3493 (16.07%) |
Angina | 291/5680 (5.29%) | 283/4814 (6.15%) | 240/3950 (7.21%) | 65/4596 (1.49%) | 95/3805 (2.91%) |
Heart Attack | 254/5680 (4.79%) | 264/4814 (5.72%) | 215/3950 (6.5%) | 68/4618 (1.55%) | 80/3815 (2.59%) |